» Articles » PMID: 18631333

Long-term Visual Prognosis of Corneal and Ocular Surface Surgery in Patients with Congenital Aniridia

Overview
Journal Acta Ophthalmol
Specialty Ophthalmology
Date 2008 Jul 18
PMID 18631333
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate the long-term visual prognosis of corneal and ocular surface surgery in patients with congenital aniridia.

Methods: Retrospective comparative interventional case series on 88 eyes of 45 patients with congenital aniridia treated and/or operated on from 1956 to present. Corneal and ocular surface findings were identified and patients were classified into operated (group I) or not operated (group II). Long-term best-ever best-corrected visual acuity (BCVA), final BCVA and long-term delta BCVA (long-term best-ever BCVA - final BCVA) were recorded and compared between the two groups, and between the limbal transplant (LT) (group I-A) and the penetrating keratoplasty (PK) (group I-B) patients. Postoperative results were also compared.

Results: Limbal insufficiency was present in 58% of eyes and dense central corneal opacities were present in 27% of eyes. As a primary surgery, limbal allograft was performed in 10 eyes and PK in 13 eyes. The mean long-term follow-up times were 23 years in group I and 16 years in group II. The mean long-term delta BCVA was 0.032 in group I and 0.028 in group II. Comparisons of the VA means were insignificant (long-term best-ever, final BCVA and long-term delta BCVA). When comparing the LT and PK groups, mean long-term delta BCVA was 0.0328 in group I-A and 0.0382 in group I-B. Mean postoperative delta BCVA was 0.028 in group I-A and 0.048 in group I-B. We found no statistical significance between the LT and the PK groups as regards long-term postoperative BCVA results.

Conclusion: Long-term visual prognosis does not differ whether or not the patient undergoes surgery for aniridic keratopathy. LT and PK have comparable results over 5 years of follow-up because of the eventual failure of transplanted allografts.

Citing Articles

Congenital aniridia beyond black eyes: From phenotype and novel genetic mechanisms to innovative therapeutic approaches.

Daruich A, Duncan M, Robert M, Lagali N, Semina E, Aberdam D Prog Retin Eye Res. 2022; 95:101133.

PMID: 36280537 PMC: 11062406. DOI: 10.1016/j.preteyeres.2022.101133.


Congenital aniridia: clinical profile of children seen at the University College Hospital, Ibadan, South-West Nigeria.

Ugalahi M, Ibukun F, Olusanya B, Baiyeroju A Ther Adv Ophthalmol. 2021; 13:25158414211019513.

PMID: 34104869 PMC: 8170280. DOI: 10.1177/25158414211019513.


Quantitative Analysis of the Association Between Follow-Up Duration and Severity of Limbal Stem Cell Deficiency or Visual Acuity in Aniridia.

Komoto S, Oie Y, Kawasaki S, Kawasaki R, Nishida N, Soma T Invest Ophthalmol Vis Sci. 2020; 61(6):57.

PMID: 32589199 PMC: 7415892. DOI: 10.1167/iovs.61.6.57.


Aniridia-related keratopathy: Structural changes in naïve and transplanted corneal buttons.

Vicente A, Bystrom B, Lindstrom M, Stenevi U, Pedrosa Domellof F PLoS One. 2018; 13(6):e0198822.

PMID: 29889891 PMC: 5995400. DOI: 10.1371/journal.pone.0198822.


Topical bevacizumab treatment in aniridia.

Lapid-Gortzak R, Santana N, Nieuwendaal C, Mourits M, van der Meulen I Int Ophthalmol. 2017; 38(4):1741-1746.

PMID: 28620705 DOI: 10.1007/s10792-017-0605-4.